Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 14Amgen Inc

02 4Sandoz B2B

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB

Brand Name : PROLIA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 125320

Regulatory Info :

Registration Country : USA

blank

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB

Brand Name : XGEVA

Dosage Form : INJECTABLE; SUBCUTANEOUS

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 125320

Regulatory Info :

Registration Country : USA

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

denosumab

Brand Name : Prolia

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 60 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

denosumab

Brand Name : Prolia

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 60 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

denosumab

Brand Name : XGEVA

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 120 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Denosumab

Brand Name : Xgeva

Dosage Form : Solution for injection, solution in pre-filled syringe

Dosage Strength : 120 mg

Packaging : Pre-filled syringe 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Denosumabum

Brand Name : Prolia

Dosage Form : Inj L?s

Dosage Strength : 60mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Denosumabum

Brand Name : Xgeva

Dosage Form : Inj Soluble

Dosage Strength : 120mg/1.7ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB

Brand Name : XGEVA

Dosage Form : SOLUTION

Dosage Strength : 120MG/1.7ML

Packaging : 1.7ML

Approval Date :

Application Number : 2368153

Regulatory Info : Prescription

Registration Country : Canada

blank

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB

Brand Name : PROLIA

Dosage Form : SOLUTION

Dosage Strength : 60MG/ML

Packaging : 1ML

Approval Date :

Application Number : 2343541

Regulatory Info : Prescription

Registration Country : Canada

blank

11

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Denosumab

Brand Name : Prolia 60 mg

Dosage Form : PFS

Dosage Strength : 60mg/ml

Packaging : 1X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

12

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

denosumab

Brand Name : Xgeva

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

13

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

denosumab

Brand Name : Xgeva

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

14

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

denosumab

Brand Name : Prolia

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

15

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB-BBDZ

Brand Name : JUBBONTI

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 761362

Regulatory Info :

Registration Country : USA

blank

16

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB-BBDZ

Brand Name : WYOST

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 120MG/1.7ML (70MG/ML)

Packaging :

Approval Date :

Application Number : 761362

Regulatory Info :

Registration Country : USA

blank

17

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB

Brand Name : WYOST

Dosage Form : SOLUTION

Dosage Strength : 120MG/1.7ML

Packaging :

Approval Date :

Application Number : 2545764

Regulatory Info : Prescription

Registration Country : Canada

blank

18

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

DENOSUMAB

Brand Name : JUBBONTI

Dosage Form : SOLUTION

Dosage Strength : 60MG/ML

Packaging :

Approval Date :

Application Number : 2545411

Regulatory Info : Prescription

Registration Country : Canada

blank